Table 1.
No. | Gender | Diagnosis | Stage | Histological Type |
CTC Count (N) |
---|---|---|---|---|---|
1 | Male | Lung cancer | IV | Adenocarcinoma | 43 |
2 | Female | Lung cancer | IV | Adenocarcinoma | 21 |
3 | Male | Lung cancer | IV | Small cell carcinoma | 6 |
4 | Male | Lung cancer | IV | Large cell carcinoma | 10 |
5 | Female | Lung cancer | IV | Adenocarcinoma | 31 |
6 | Male | Lung cancer | IV | Adenocarcinoma | 9 |
7 | Male | Lung cancer | IV | Adenocarcinoma | 0 |
8 | Female | Lung cancer | IIIC | Adenocarcinoma | 15 |
9 | Female | Lung cancer | IV | Adenocarcinoma | 13 |
10 | Male | Lung cancer | Postoperative | Adenocarcinoma | 0 |
11 | Male | Lung cancer | IIA | Adenocarcinoma | 14 |
12 | Female | Lung cancer | IV | Adenocarcinoma | 9 |
13 | Female | Lung cancer | IV | Adenocarcinoma | 12 |
14 | Male | Lung cancer | IV | Squamous cell carcinoma | 17 |
15 | Female | Lung cancer | IIIB | Adenocarcinoma | 6 |
16 | Male | Lung cancer | IA | Adenocarcinoma | 26 |
17 | Male | Pneumonia | — 2 | — 2 | 0 |
18 | Male | COPD 1 | — 2 | — 2 | 0 |
19 | Male | COPD 1 | — 2 | — 2 | 0 |
20 | Male | COPD 1 | — 2 | — 2 | 0 |
1 COPD, chronic obstructive pulmonary disease; 2 “—”, no such information.